|
JAMA Network Open |
Risks of SARS-CoV-2 Breakthrough Infection and Hospitalization in Fully Vaccinated Patients With Multiple Myeloma |
1 |
Yes |
11/24/2024 |
|
JAMA Network Open |
Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden |
1 |
Yes |
12/21/2024 |
|
JAMA |
RNA Interference With Zilebesiran for Mild to Moderate Hypertension - The KARDIA-1 Randomized Clinical Trial |
1 |
Yes |
2/16/2027 |
|
AMA Journal of Ethics |
Roles of Environmental Services Workers' Wages and Status in Patient Safety |
1 |
Yes |
9/1/2025 |
|
AMA Journal of Ethics |
Roles of Graphic Pathographies in Clinical Training |
1 |
Yes |
1/23/2027 |
|
AMA Journal of Ethics |
Roles of Randomized Controlled Trials in Establishing Evidence-Based Gender-Affirming Care and Advancing Health Equity |
1 |
Yes |
8/31/2027 |
|
JAMA Dermatology |
Rosacea Core Domain Set for Clinical Trials and Practice - A Consensus Statement |
1 |
Yes |
4/24/2027 |
|
JAMA Network Open |
Routine Surveillance and Vaccination on a University Campus During the Spread of the SARS-CoV-2 Omicron Variant |
1 |
Yes |
5/31/2025 |
|
JAMA Otolaryngology – Head & Neck Surgery |
Saddle-Nose Deformity in the Setting of Diffuse Cutaneous Lesions in an African American Man |
1 |
Yes |
7/21/2025 |
|
JAMA Network Open |
Safety and Adverse Events Among Long-term Care Residents Receiving a Third COVID-19 mRNA Vaccine Booster Dose in Quebec |
1 |
Yes |
8/1/2025 |
|
JAMA Dermatology |
Safety and Effectiveness of Oral Nutraceuticals for Treating Acne - A Systematic Review |
1 |
Yes |
10/25/2026 |
|
JAMA Network Open |
SARS CoV-2 Seroprevalence in Selected States of High and Low Disease Burden in Nigeria |
1 |
Yes |
10/26/2025 |
|
JAMA Internal Medicine |
SARS-CoV-2 Antibody Response After ChAdOx1 nCoV-19 Vaccination in Persons With Previous SARS-CoV-1 Infection |
1 |
Yes |
1/26/2025 |
|
JAMA Oncology |
SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer Agents |
1 |
Yes |
1/14/2025 |
|
JAMA Oncology |
SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer Agents |
1 |
Yes |
1/14/2025 |
|
JAMA Network Open |
SARS-CoV-2 Attack Rate and Population Immunity in Southern New England, March 2020 to May 2021 |
1 |
Yes |
5/31/2025 |
|
JAMA |
SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents From Colorado, USA, and Bavaria, Germany |
1 |
Yes |
10/26/2025 |
|
JAMA |
SARS-CoV-2 Infections in Close Contacts of Positive Cases in the Olympic and Paralympic Village at the 2021 Tokyo Olympic and Paralympic Games |
1 |
Yes |
2/4/2025 |
|
JAMA Network Open |
SARS-CoV-2 Polymerase Chain Reaction Positivity Rates Among Evacuees From Afghanistan After Withdrawal of the Coalition Forces |
1 |
Yes |
5/31/2025 |
|
JAMA Network Open |
SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India |
1 |
Yes |
1/14/2025 |
